Trials / Conditions / Irritable Bowel Syndrome Characterized by Constipation

Irritable Bowel Syndrome Characterized by Constipation

12 registered clinical trials studyying Irritable Bowel Syndrome Characterized by Constipation — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Withdrawn	Botanical Tincture for Symptoms of Irritable Bowel Syndrome NCT03923322	Stamford Hospital	Phase 2
Withdrawn	A Non-Interventional Pilot Study to Explore the Role of Gut Flora in IBS NCT04214470	ProgenaBiome	—
Recruiting	Low FODMAP Plus PEG 3350 for the Treatment of Patients with Irritable Bowel Syndrome-Constipation NCT03687814	University of Michigan	N/A
Completed	A Trial of Linaclotide 290 μg in Patients With Irritable Bowel Syndrome With Constipation (IBS-C) NCT03573908	Ironwood Pharmaceuticals, Inc.	Phase 3
Unknown	Reclassifying Constipation Using Imaging and Manometry NCT03226145	University of Nottingham	N/A
Terminated	A Study of the Effect of Linaclotide on Abdominal Girth in Participants With Irritable Bowel Syndrome With Con NCT02837783	Ironwood Pharmaceuticals, Inc.	Phase 4
Completed	Food Supplement Physiomanna® Baby in Pediatric Patients NCT02732743	Iuppa Industriale Srl	N/A
Completed	Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C) NCT02493452	Bausch Health Americas, Inc.	Phase 3
Completed	The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C) NCT02387359	Bausch Health Americas, Inc.	Phase 3
Completed	The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C) NCT01722318	Bausch Health Americas, Inc.	Phase 2
Completed	Mode of Action of Moviprep NCT01622972	University of Nottingham	Phase 4
Completed	Trial of Linaclotide Administered to Patients With Irritable Bowel Syndrome With Constipation NCT00948818	Forest Laboratories	Phase 3